Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Ankylosing Spondylitis | Treatment Algorithms | Claims Data Analysis | US | 2015
Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily affects the spine and axial skeleton, causing pain and greatly impacting quality of life. Diagnosis can be difficult,…
Malignant Melanoma | Emerging Therapies | Keytruda (pembrolizumab) | US | Wave 3 | 2015
LaunchTrends: Keytruda Wave 3 (US) is the third in a series of syndicated reports designed to track physician perception, uptake, and competitive environment regarding the malignant melanoma drug…
Hereditary Angioedema | Niche & Rare Disease Landscape & Forecast | US/EU5 | 2015
Mutations in the gene coding for C1-inhibitor (C1-INH) protein result in hereditary angioedema (HAE), whereby insufficient levels of C1-INH or abnormal forms of the protein ultimately result in…
Prostate Cancer (U.S. Physician and Payer Perspectives on Novel Treatment Options for Prostate Cancer) | Physician & Payer Forum | US | 2015
The U.S. Physician and Payer Perspectives on Novel Treatment Options for Prostate Cancer report surveyed 50 medical oncologists, 52 urologists, and 30 MCO pharmacy and medical directors to capture…
Hepatitis B Virus (Reimbursement and Market Access Dynamics Against a Backdrop of High Prevalence) | Physician & Payer Forum | China | 2015
China has the greatest burden of hepatitis B and liver cancer in the world. In 2014 chronic hepatitis B virus (HBV) infection affected nearly 89.8 million people in China; we expect the total…
Chronic Obstructive Pulmonary Disease | Treatment Algorithms | Claims Data Analysis | US | 2015
For the estimated 9 million patients diagnosed with chronic obstructive pulmonary disease (COPD) in the United States, there are multiple prescription therapies that are available for treating the…
